Brief: Aethlon Advances Hemopurifier® Study In Solid Tumors Not Responding To Anti-PD-1 Antibodies
29/01/2025 13:04
Jan 29 (Reuters) - Aethlon Medical Inc AEMD.O :
* AETHLON MEDICAL TREATS FIRST PATIENT IN AUSTRALIAN
HEMOPURIFIER®
CANCER TRIAL
* AETHLON MEDICAL : AETHLON ADVANCES HEMOPURIFIER® STUDY IN
SOLID
TUMORS NOT RESPONDING TO ANTI-PD-1 ANTIBODIES
Source text: ID:nPn8gc5Gna
Further company coverage: AEMD.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology